Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Clinical trial NCT06793137 · RECRUITING

Trial details

NCT number: NCT06793137
Sponsor: AC Camargo Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rectal Cancer, Adenocarcinoma

Start date: 2024-07-22
Primary completion: 2025-10-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.